Prior information notice
This notice is for prior information only
Section I: Contracting
authority
I.1) Name and addresses
NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust)
Procurement Department, Cardiff and Vale University Local Health Board, Brecknock House, 8th Floor, University Hospital of Wales, Heath Park
Cardiff
CF14 4XW
UK
Telephone: +44 2920746577
E-mail: amy.slocombe@wales.nhs.uk
NUTS: UK
Internet address(es)
Main address: http://www.procurement.wales.nhs.uk
Address of the buyer profile: https://www.sell2wales.gov.wales/search/Search_AuthProfile.aspx?ID=AA0221
I.2) Joint procurement
The contract is awarded by a central purchasing body
I.3) Communication
Additional information can be obtained from the abovementioned address
I.4) Type of the contracting authority
Body governed by public law
I.5) Main activity
Health
Section II: Object
II.1) Scope of the procurement
II.1.1) Title
Flow Triever Catheter System
II.1.2) Main CPV code
33141200
II.1.3) Type of contract
Supplies
II.1.4) Short description
NHS Wales Shared Services Partnership, on behalf of Cardiff and Vale University Health Board wish to inform the market that they intend to award Inari Medical a contract to supply 20 cases of the Inari Flow Triever.
II.1.5) Estimated total value
Value excluding VAT:
130 000.00
GBP
II.1.6) Information about lots
This contract is divided into lots:
No
II.2) Description
II.2.2) Additional CPV code(s)
33141240
33141200
II.2.3) Place of performance
NUTS code:
UKL22
II.2.4) Description of the procurement
Throughout 2021, Cardiff and Vale Health Board has been conducting a trial for the Inari Flow Triever.
The device is used for the mechanical aspiration of blood clots when treating high risk, acute pulmonary embolism. The Inari device has a calibre up to three times the diameter of similar devices.
Currently, the health board uses two other systems, which will continue to be used in appropriate cases. Through the acquisition of the Inari Flow Triever, the health board will be able to treat large clot presentations with greater flexibility, resulting in decreased mortality and morbidity.
Without this purchase the health board will be unable to provide optimal treatment modalities for high-risk patients. This will result in an increased need for critical care access with a high incidence of mortality.
II.3) Estimated date of publication of contract notice:
28/01/2022
Section IV: Procedure
IV.1) Description
IV.1.8) Information about Government Procurement Agreement (GPA)
The procurement is covered by the Government Procurement Agreement:
Yes
Section VI: Complementary information
VI.3) Additional information
NOTE: To register your interest in this notice and obtain any additional information please visit the Sell2Wales Web Site at https://www.sell2wales.gov.wales/Search/Search_Switch.aspx?ID=117072.
(WA Ref:117072)
VI.5) Date of dispatch of this notice
22/12/2021